Innospec Q2: Revenue Climbs 12%, EPS Hits $1.25, Debt-Free with $250M Cash
IOSP sits 32% above its 52-week low of $65.51.
Summary
Innospec reported Q2 2026 revenue of $491.4 million (+12% YoY) and GAAP EPS of $1.25, beating estimates. The company remains debt-free with $250.2 million in net cash and repurchased $6.4 million in shares.
Key Events · Earnings and Guidance · IOSP
-
Strong Q2 Revenue and Earnings Beat
Revenue rose 12% YoY to $491.4 million, with GAAP EPS of $1.25 versus $0.94 a year ago. Adjusted non-GAAP EPS was $1.27, slightly above last year's $1.26.
-
Broad-Based Segment Growth
Performance Chemicals operating income up 15%, Fuel Specialties up 3%, and Oilfield Services up 40%, all contributing to a 16% increase in total operating income.
-
Robust Balance Sheet and Capital Returns
Company ended the quarter with $250.2 million in net cash and no debt. It paid a semi-annual dividend of $0.92 per share and repurchased $6.4 million in stock.
-
Positive Second-Half Outlook
Management expects further sequential improvement in Performance Chemicals and Oilfield Services, and increased operating cash flow from better working capital efficiency.
Analysis · IOSP · Industrial Applications And Services
A strong second quarter saw Innospec beat expectations, with revenue climbing 12% to $491.4 million and GAAP EPS reaching $1.25—well above the prior year's $0.94. All three business segments contributed to double-digit operating income growth. The company remains debt-free and holds over $250 million in net cash, providing significant flexibility for organic investment, M&A, dividends, and buybacks. Management expects further improvement in the second half of 2026, driven by ongoing operational initiatives.
At the time of this filing, IOSP was trading at $86.70 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.1B. The 52-week trading range was $65.51 to $92.14. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.